LexDanaLexDanabeta
Inventor

JEREMY ODEGARD

Inventor
US

Overview

2→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Fprimary
A61FFilters implantable into blood vessels50%
A61MDevices for introducing media into, or onto, the body50%
PatentTitleYear
D1116103Dose delivery device202611,439,758Devices and methods for precision dose delivery2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to REGENERON PHARMA (2)· patent assignee history
2022–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REGENERON PHARMA22022–2026
Locations
LocationPatentsSpan
US22022–2026